SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-18-007460
Filing Date
2018-07-09
Accepted
2018-07-09 17:01:43
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3 v070918_s-3.htm S-3 198319
2 EXHIBIT 5.1 v070918_ex5-1.htm EX-5.1 17905
3 EXHIBIT 23.1 v070918_ex23-1.htm EX-23.1 6278
4 IMAGE tgtx-novimmunesashelfonfo000.jpg GRAPHIC 3448
  Complete submission text file 0001654954-18-007460.txt   228702
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-226097 | Film No.: 18945274
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences